Related by context. All words. (Click for frequent words.) 68 asymptomatic carriers 68 external genital lesions 67 HBeAg negative 67 chronic HBV 67 seropositivity 67 chlamydial infection 67 quadrivalent vaccine 66 serologic testing 66 etiologic agent 66 anal HPV 66 Trichomonas vaginalis 66 coinfection 66 varicella infection 66 NNRTI resistance 66 HER2 positive cancers 66 LTBI 66 hepatitis C genotype 66 cervical vaginal 65 precursor lesions 65 oral poliovirus 65 KRAS mutations occur 65 cervical vulvar 65 Human papillomavirus HPV 65 monoinfected patients 65 Human papilloma virus 65 NRTI resistance 65 cervical HPV 65 ASCUS 65 C. trachomatis 65 Human papillomavirus 65 serogroups 65 candidemia 65 HPV-#/# 65 K ras mutations 65 vaginal cancers 65 Chlamydia infection 65 viral subtypes 64 neoplasias 64 ano genital warts 64 seronegative 64 fluoroquinolone resistance 64 HIV uninfected 64 advanced adenoma 64 oncogenic HPV 64 sero positive 64 HIV coinfected 64 S. aureus infection 64 sexually transmitted HPV 64 oncogenic HPV types 64 P aeruginosa 64 poor metabolizers 64 HPV Types 64 MRSA colonization 64 Chlamydia trachomatis 64 tuberculin skin testing 64 anal cancers 64 low expressors 64 invasive lobular 63 CIN3 + 63 genital human papillomavirus 63 N. meningitidis 63 quadrivalent 63 HPVs 63 IgA deficiency 63 herpesviruses 63 clade B 63 Opportunistic infections 63 cervical intraepithelial neoplasia 63 antibody titer 63 ALT flares 63 HPV types 63 serologically 63 precancerous cervical lesions 63 genital HSV 63 chlamydial infections 63 cervical lesions 63 nonvaccine 63 vaccine serotypes 63 genotypic resistance 63 renal cell carcinomas 63 CIN2 + 63 P. falciparum malaria 63 KRAS status 63 quadrivalent human papillomavirus 63 HPV# 63 advanced neoplasia 63 serogroup B 62 recurrent genital herpes 62 pneumococcal infection 62 noninfected 62 invasive carcinoma 62 Salmonella typhi 62 abnormal Pap smears 62 HPV genotypes 62 grade cervical dysplasia 62 vaginal lesions 62 HBV infections 62 perinatally 62 HCV replicon 62 HER2 expression 62 FluCAM arm 62 simplex virus 62 Rimantadine 62 CCR5 tropic HIV 62 R5 tropic 62 anti HBs 62 severe rotavirus gastroenteritis 62 Chlamydia trachomatis infection 62 genital herpes infections 62 human herpesvirus 62 USA# strain 62 CIN3 62 CMV disease 62 abnormal pap smears 62 gonococcal infections 62 MRSA isolates 62 HSV1 62 Plasmodium ovale 62 K#N 62 BRCA1 mutation carriers 62 invasive ductal breast cancer 62 WNV infections 62 vaccinees 62 precancerous cervical 62 prostate cancer CaP 62 superinfection 62 hepatitis B infection 62 hormone receptor negative 62 valent pneumococcal conjugate vaccine 62 dengue haemorrhagic fever DHF 62 S. aureus infections 62 CIN2 62 HGPIN 62 T. vaginalis 62 Squamous 62 Recombinant interferon alpha 62 hepatocellular carcinomas 62 virologic responses 62 varicella zoster virus VZV 62 gonococcal infection 62 chronic HBV infection 61 causal variants 61 relapsed MM 61 NNRTI resistant virus 61 Tindamax R 61 genital ulcer disease 61 gastric carcinoma 61 genital HPV 61 Candida species 61 ESBL producing E. coli 61 invasive carcinomas 61 metastatic neuroendocrine tumors 61 CMV infection 61 extracolonic findings 61 HER2 overexpression 61 pulmonary metastases 61 oral squamous cell 61 S. aureus isolates 61 recurrent VTE 61 Genital herpes 61 atypical ductal hyperplasia 61 missense mutations 61 IgM antibodies 61 nucleotide analog 61 varicella chickenpox 61 squamous cell lung cancer 61 orchitis 61 enteroviral 61 herpes zoster shingles 61 Bordetella pertussis 61 S aureus 61 genital HPV infection 61 Herpes Simplex Virus 61 grade cervical intraepithelial 61 genital ulcers 61 dose intramuscular 61 heterosexually acquired 61 empiric therapy 61 BRSV 61 bacterium Neisseria meningitidis 61 genital ulcer 61 fetal chromosomal 61 MGUS 61 intestinal metaplasia 61 KRAS mutations 61 Chlamydia infections 61 skeletal metastases 61 HIV seropositive 61 germline mutations 61 locoregional recurrence 61 chorioamnionitis 61 penile anal 61 hemorrhagic cystitis 61 E7 proteins 61 chronic HCV 61 Aspergillus infections 61 HBsAg 61 P falciparum 61 malignant neoplasm 61 micafungin 61 pemphigus vulgaris 61 Epstein Barr virus EBV 61 lymphocytosis 61 mesotheliomas 61 Anaplasma 61 chronic hepatitis cirrhosis 61 p# biomarker 61 genetic variants associated 61 microbiologically evaluable 61 HBV genotype 61 HIV1 61 PCNSL 61 complete cytogenetic response 61 A. phagocytophilum 60 capsular polysaccharide 60 H. influenzae 60 seroprevalence 60 anogenital warts 60 M#V mutation 60 Human Papillomavirus 60 ovarian breast 60 postexposure prophylaxis 60 trichomonas 60 Streptococcus pneumonia 60 endometrial hyperplasia 60 Staphylococcus aureus infections 60 rotaviruses 60 M. pneumoniae 60 H5 viruses 60 chlamydial 60 epithelial tumors 60 endocrine therapies 60 nonsmall cell lung cancer 60 Genital HPV 60 humoral responses 60 abnormal Pap smear 60 recurrent metastatic 60 gonorrhoeae 60 S. aureus bacteria 60 K ras gene 60 NNT = 60 N. gonorrhoeae 60 Human Papilloma Virus 60 cervical carcinoma 60 antiviral prophylaxis 60 pneumococcal serotypes 60 myeloproliferative diseases 60 hepatorenal syndrome 60 cytoreduction 60 dysplastic lesions caused 60 HAV infection 60 methicillin resistant MRSA 60 causative pathogen 60 BCG vaccinated 60 invasive fungal infection 60 expressors 60 penile cancers 60 GIST tumors 60 HCV genotype 60 immunocompetent 60 B7 H3 60 S OIV 60 susceptibility loci 60 GARDASIL ® 60 beta estradiol 60 hepatitis B immunoglobulin 60 CP CPPS 60 antimicrobial prophylaxis 60 dose cohort 60 precancers 60 Pneumocystis carinii pneumonia 60 ertapenem 60 budesonide foam 60 histological subtype 60 histologic subtype 60 pneumococci 60 fetal malformations 60 secondary amenorrhea 60 pancreatic prostate 60 nodal metastasis 60 EGFR mutations 60 serologic tests 60 serum aminotransferase levels 60 chronic HCV genotype 60 KRAS oncogene 60 TGFBR1 * 6A 60 lymphoma subtypes 60 GBA mutations 60 trivalent inactivated influenza 60 serotype #A 60 GABHS 60 Pneumococcal pneumonia 60 abnormal cytology 60 Streptococcus pneumoniae serotypes 60 HAAH 60 chlamydia trachomatis 60 posaconazole 60 MenACWY 60 caspofungin 60 Heavy menstrual bleeding 60 biologic DMARD 60 WNV infection 60 HER2 gene 60 FGFR2 gene 60 chlamydia sexually transmitted 60 serologic 60 GISTs 60 neuroblastoma tumors 60 K#R [002] 60 acne vulgaris 60 PASI scores 60 human papilloma 60 gonococcal 60 colorectal polyp 60 LRAT 60 nonmelanoma skin cancers 60 tigecycline 60 advanced adenomas 60 mIU ml 60 cryptococcal meningitis 60 lymphogranuloma venereum 60 serogroup C 59 Balamuthia 59 pituitary adenomas 59 gastric adenocarcinoma 59 ADPKD 59 anemia hemoglobin 59 Thyroid nodules 59 Hurthle cell 59 tumor histology 59 Plasmodium vivax 59 lymphocytic choriomeningitis virus LCMV 59 microdeletions 59 intracranial hemorrhage ICH 59 vulvar cancer 59 VZV 59 fluconazole resistant 59 treatment naive genotype 59 ovarian endometrial 59 dysplastic lesions 59 chronic HCV infection 59 papillomavirus 59 AGHD 59 H pylori 59 serous ovarian cancer 59 hypereosinophilic syndrome 59 benign noncancerous 59 MAGE A3 ASCI 59 genital lesions 59 aged ≥ 59 undetectable hepatitis C 59 HCV infection 59 HBV vaccine 59 Hib disease 59 RhD negative 59 G CSFs 59 virus HBV 59 HCV infections 59 % CI #.#-#.# [003] 59 gastrointestinal stromal tumors GISTs 59 HCV genotypes 59 Enterobacter cloacae 59 thyroid carcinoma 59 BRCA2 mutation carriers 59 SLNB 59 sentinel nodes 59 M. bovis 59 ALT elevation 59 MCV4 59 Serotype 59 P. vivax malaria 59 chromosomal alterations 59 CCR5 tropic 59 rectal gonorrhea 59 human papillomaviruses 59 latent celiac disease 59 ductal breast cancer 59 UGT#A# * 59 BARACLUDE ® 59 Radical prostatectomy 59 sonographic diagnosis 59 MAGE A3 protein 59 System IPSS 59 enteroviral infection 59 P. ovale 59 S.aureus 59 etiologic 59 Respiratory Syncytial Virus RSV 59 C. pneumoniae 59 pneumonia tetanus 59 coinfected 59 antiangiogenic drugs 59 thyrotropin levels 59 S. maltophilia 59 Multidrug resistant 59 rhinovirus infection 59 cervicitis 59 anti JCV antibodies 59 nonpregnant women 59 foodborne infections 59 pH#N# 59 tipranavir ritonavir 59 circulating influenza viruses 59 HCV antibody 59 subtyped 59 HER2 amplification 59 simian foamy virus 59 chromosomal rearrangement 59 Pneumococcal vaccines 59 differentiated thyroid 59 discontinued Viread 59 T1c 59 RAS mutations 59 parasitemia 59 HPV strains 59 postexposure 59 macrolide antibiotic 59 Salmonella spp 59 neurologic complications 59 bacterial vaginosis BV 59 invasive Hib 59 enterococcal 59 M. genitalium 59 HbF 59 oseltamivir resistant 59 alemtuzumab treated 59 BRCA mutation carriers 59 childhood leukemias 59 bacteriuria 59 Medullary thyroid cancer 59 MenB 59 IgG antibody 59 mediastinitis 59 human papillomavirus HPV 59 HIV serostatus 59 pediatric acute lymphoblastic 59 lymphoid tumors 59 measles mumps rubella varicella 59 Novartis MenB vaccine 59 HNSCC 59 urethritis 59 obstructive coronary artery 59 TNF blocker therapy 59 H Pylori 59 nonvaccine serotypes 59 Herpes zoster 59 influenza antiviral medications 59 papillary renal cell carcinoma 59 GBMs 59 latent tuberculosis infection 59 #mg dose [002] 59 hematologic abnormalities 59 valent vaccine 59 pCR 59 M#V 59 Pseudomonas aeruginosa infections 59 G6PD deficiency 59 Postoperative complications 59 dengue viruses 59 vulvar cancers 59 osteoporotic vertebral compression fractures 59 sCJD 59 recurrent glioblastoma multiforme 59 HSV2 59 APOE e4 59 seroprotection 58 renal scarring 58 acinetobacter 58 metastatic lymph nodes 58 Herpes simplex virus 58 toxoplasma 58 lichen planus 58 viral isolates 58 transfusion transmitted 58 immuno compromised individuals 58 Human Papillomavirus Quadrivalent Types 58 brivanib 58 squamous intraepithelial lesions 58 ToGA 58 nonnucleoside reverse transcriptase inhibitors 58 Escherichia coli Klebsiella pneumoniae 58 MYH9 gene 58 diabetes mellitus DM 58 seroconversion 58 microscopic colitis 58 invasive aspergillosis 58 dengue hemorrhagic fever DHF 58 polio hepatitis B 58 endometrial ovarian 58 distinct subtypes 58 serodiscordant couples 58 diagnosed prenatally 58 vancomycin resistant 58 Neisseria gonorrhoeae 58 Human Virus HPV 58 Helicobacter pylori H. pylori 58 urogenital infections 58 relapsed ALL 58 hemagglutination inhibition 58 Trichophyton rubrum 58 aphthous stomatitis 58 GBM tumors 58 HBeAg positive patients 58 receptive anal sex 58 immunodeficient 58 CA MRSA infections 58 C#Y 58 causative mutation 58 acellular pertussis DTaP 58 BRCA2 carriers 58 quinolone resistant 58 stratifying patients 58 de novo AML 58 reduce serum phosphate 58 tropism testing 58 anal lesions 58 VFEND 58 causative organism 58 CMV infections 58 atopic disorders 58 methicillin sensitive 58 efalizumab 58 nucleotide substitutions 58 IGRAs 58 trivalent influenza vaccine 58 breast carcinoma 58 thromboembolic disease 58 live attenuated intranasal 58 neoplastic cells 58 RhD 58 colorectal neoplasms 58 latently infected 58 TYGACIL 58 diagnostic biomarker 58 bacterium Mycobacterium tuberculosis 58 Cytomegalovirus CMV 58 Nonalcoholic fatty liver 58 chronic lyme 58 enterovirus infection 58 shingles vaccine Zostavax 58 human metapneumovirus 58 Genetic variants 58 testicular tumors 58 Epidemiologic studies 58 Salmonella Campylobacter 58 Partial Responses 58 antiretroviral naïve 58 HBV infection 58 Chlamydia pneumoniae 58 renal tumors 58 L. pneumophila 58 % CI #.#-#.# [007] 58 cervical precancerous lesions 58 leiomyomas 58 smoldering myeloma 58 abacavir Ziagen 58 sonographically 58 causative mutations 58 HIV seronegative 58 differentially expressed genes 58 metastatic bladder 58 DAS# CRP 58 BALB c mice 58 urolithiasis 58 serotypes 58 distal colon cancer 58 eosinophilic pneumonia 58 minimally symptomatic metastatic castrate 58 octreotide LAR 58 neutrophil counts 58 MDR tuberculosis 58 parasitaemia 58 DEB# 58 allogeneic HSCT 58 LymphoStat B belimumab 58 splice variants 58 EGFR mutant 58 Latex condoms 58 pharmacologic intervention 58 LVNC 58 MUC1 protein 58 TroVax ® 58 Epstein Barr Virus EBV 58 Chronic lymphocytic leukemia 58 Pandemic Influenza H#N# 58 EGFR mutation 58 HIV seroconversion 58 alpha2 58 monogenic 58 oesophageal adenocarcinoma 58 liposomal amphotericin B 58 Immunohistochemical analysis 58 candidiasis 58 sputum specimens 58 Bacterial vaginosis 58 Human Papilloma 58 enteroviruses 58 elevated CRP 58 breast endometrial 58 Chlamydia gonorrhea 58 CCR5 delta# 58 PPSV# 58 metastatic lung cancer 58 colorectal cancer CRC 58 immunohistochemical staining 58 CD8 responses 58 Hepatitis B virus 58 D#N 58 ORFs 58 murine leukemia virus 58 elevated LDH 58 microsatellite instability 58 KRAS mutation 58 virologic 58 fluoroquinolone resistant 58 griseofulvin 58 pretreatment serum 58 anaphylactic reactions bronchospasm 58 Genital warts 58 parainfluenza 58 Multivariate analysis 58 nosocomial infection 58 A/H#N# strain 58 M. leprae 58 Plasmodium infection 58 BI/NAP#/# 58 KIF6 gene 58 microbial keratitis 58 Liver cirrhosis 58 methicillin susceptible Staphylococcus aureus 58 slow progressors 58 cytomegalovirus CMV 58 TCF#L# gene 58 osteosarcomas 58 attending antenatal clinics 58 #q# deletion 58 IgG antibodies 58 Listeria infections 58 Lymphocytic 58 abnormal vaginal bleeding 58 XDR tuberculosis 58 latent TB infection 58 otitis media ear 58 urothelial carcinoma 58 metastatic lesions 58 HBeAg seroconversion 58 curative resection 58 ABCB1 58 Candida infection 58 PAOD 58 Shigella bacteria 58 colorectal adenoma 58 asymptomatically 58 Immune responses 58 Kaplan Meier analysis 58 BRAF V#E mutation 58 molecular abnormalities 58 Clostridium difficile infections 58 BRAF mutations 58 Plasmodium falciparum parasite 58 pneumocystis 58 susceptible isolates 58 pandemic influenza virus 57 S. enterica 57 virus subtype 57 ASD prevalence 57 underwent resection 57 adjuvant therapies 57 cytogenetic abnormalities 57 demyelinating 57 Plasmodium falciparum malaria 57 chlamydia gonorrhea syphilis 57 hepatocellular carcinoma liver 57 methylation markers 57 E. faecalis 57 invasive ductal 57 bloodborne 57 ESBLs 57 genital HPV infections 57 recurrent venous thromboembolism 57 astrocytomas 57 cervical cancer precancerous 57 nonsevere 57 ALK inhibitors 57 intraepithelial neoplasia 57 venous blood clots 57 coinfected patients 57 hypophosphatemia 57 pegylated IFN 57 heterozygotes 57 serogroup 57 clinically asymptomatic 57 malignant lesions 57 inactivated vaccines 57 metastatic gastric 57 papilloma virus 57 pelvic malignancies 57 HPAI H#N# 57 underwent surgical resection 57 Acute myeloid leukemia 57 solithromycin 57 hamartomas 57 NOMID 57 grade squamous intraepithelial 57 biochemical relapse 57 streptococcus bacterium 57 acute respiratory tract infections 57 herpes zoster vaccine 57 GBV C 57 nonpregnant 57 Postherpetic neuralgia 57 localized prostate 57 BRAF mutation 57 follicular adenoma 57 HIV HCV coinfected 57 bacteraemia 57 bacterial keratitis 57 ErbB2 positive 57 chemoprophylaxis 57 Ixiaro 57 diphtheria pertussis whooping cough 57 plasma kallikrein 57 cytokeratin 57 TransVax TM 57 cotrimoxazole 57 Vesivirus 57 Ectopic pregnancy 57 EUS FNA 57 causative agents 57 chlamydia herpes 57 C. diff infections 57 Entamoeba histolytica 57 proctitis 57 radezolid 57 baseline LDH 57 FLT3 57 parasite Plasmodium falciparum 57 atypical hyperplasia 57 CC genotype 57 pheochromocytoma 57 papillomaviruses 57 HPV Human Papillomavirus 57 elevated triglyceride levels 57 C difficile infection 57 premalignant lesion 57 careHPV 57 cynomolgus macaques 57 aneuploid 57 gestational diabetes mellitus GDM 57 Plasmodium species 57 VAX# 57 Genotypes 57 Polycythemia vera 57 PROSTVAC VF 57 invasive candidiasis 57 Chronic myeloid leukemia 57 IPAH 57 unprotected receptive anal 57 EBV infection 57 node metastases 57 Hib meningitis 57 sulfamethoxazole 57 inherited mutations 57 primary humoral immunodeficiency 57 adenomatous polyps 57 laparoscopically assisted 57 tryptase 57 cutaneous squamous cell carcinoma 57 curability 57 parainfluenza virus 57 huC# DM4 57 subtype 57 nasal carriage 57 neuroendocrine carcinoma 57 narcolepsy cataplexy 57 Interferon beta 1b 57 intranasal mist 57 Actinic Keratosis 57 heritable variation 57 prevalent sexually transmitted 57 tumor xenograft models 57 non adjuvanted vaccine 57 inhibitory antibodies 57 plague bacterium Yersinia 57 immune reconstitution syndrome 57 uncircumcised males 57 rs# [004] 57 hereditary predisposition 57 coagulation disorders 57 cotrimoxazole prophylaxis 57 combination antiretroviral therapy 57 HHV 6 57 treat enlarged prostate 57 ORENCIA ® 57 oral herpes 57 STEC O# 57 somatostatin analogues 57 nosocomial pneumonia 57 NMIBC 57 receiving antiretroviral therapy 57 dermatophytes 57 kidney urologic 57 Subgroup analyzes 57 prostate cancer PCa 57 4CMenB 57 chronic periodontitis 57 Leukemias 57 Endometrial 57 del 5q MDS 57 coinfections 57 Pelvic Inflammatory Disease 57 vivax 57 T#I [002] 57 HIV tropism 57 Vitaxin 57 Fluzone Intradermal vaccine 57 im peramivir 57 immunosuppressed patients 57 lipohypertrophy 57 JAK2 mutation 57 latent tuberculosis TB 57 basal cell cancers 57 florbetaben 57 R entecavir 57 B streptococcal 57 meningococcal conjugate vaccine 57 rhinovirus infections 57 malaria endemic regions 57 oropharyngeal candidiasis OPC 57 polyp recurrence 57 HLA DQ2 57 lobular cancer 57 papillomas 57 osteopenic 57 immuno compromised patients 57 Supplementary Table 57 BRCA2 mutations 57 FGFR2 57 hypermethylated 57 orf virus 57 mutated K ras 57 ethambutol 57 hepatocellular cancer 57 acid phosphatase PAP 57 bacteria campylobacter 57 initiating antiretroviral therapy 57 galiximab 57 adeno 57 EXJADE 57 S/GSK# 57 anemia neutropenia 57 TTR amyloidosis 57 vWD 57 cSSSIs 57 acquire genital HPV 57 HLA DRB1 57 pathogenic mechanisms 57 EGFR mutation positive 57 adverse reactions occurring 57 EHEC infections 57 orthopoxvirus 57 JAK mutations 57 peritoneal cancer 57 hepatitis C HCV 57 enterotoxigenic E. coli 57 serological tests 57 etiological agent 57 Adjuvant chemotherapy 57 immunized monkeys 57 clinically heterogeneous 57 CHIKV 57 Candidiasis 57 familial pancreatic cancer 57 tumorigenicity 57 falciparum 57 amebiasis 57 squamous histology 57 immunosuppressive therapies 57 oropharyngeal cancer 57 decompensated liver disease 57 microbiological eradication 57 TMPRSS2 ERG fusion 57 RSV prophylaxis 57 CDK4 57 neoplasms 57 anagrelide 57 Candida infections 57 CCR5 receptor antagonist 57 biologic pathway 57 perianal warts 57 evaluable subjects 57 microscopic hematuria 57 hepatitis B virus HBV 57 G allele 57 Immunohistochemical staining 57 lymphoid organs 57 ANCA associated 57 Thiovir 57 RSV infections 57 cisplatin resistant 57 Typhimurium 57 serovar 57 ZOSTAVAX 57 Human Papilloma virus 57 herpes chlamydia 57 HBeAg 57 Lung transplantation 57 adeno associated viruses 57 Zavesca R 57 FDG uptake 57 medulloblastoma tumors 57 TB bacilli 57 breast carcinomas 57 atypical scrapie 57 TKI therapy 57 ritonavir boosted protease inhibitor 57 IL#B 57 gestational hypertension 57 adenomatous 57 Human Papilloma Virus HPV 57 renal biopsy 57 FDG PET imaging 57 cardiac troponin T 57 Trypanosoma 57 statistical significance p 57 ALI ARDS 57 swine influenza A/H#N# 57 WNv 56 FLT3 mutations 56 cervical dysplasia 56 histologically confirmed 56 RhuDex ® 56 malignant lymph nodes 56 bacterial vaginosis 56 CYP#D# gene 56 pT2 56 castrate resistant 56 Hib vaccines 56 cryptococcosis 56 H5 influenza 56 neutralizing antibody 56 Mantoux test 56 HBeAg negative patients 56 Bacille Calmette Guerin BCG 56 Uterine cancer 56 promoter methylation 56 undetectable HBV DNA 56 log# reduction 56 Bacillus Calmette Guerin BCG 56 clostridial diseases 56 Staphylococcus aureus MRSA 56 #.#ng/ml 56 pandemic influenza A/H#N# 56 inhibit EGFR 56 Abacavir 56 zoster 56 efavirenz Sustiva 56 quadrivalent HPV vaccine 56 unexplained mental retardation 56 Xelox 56 RDTs 56 indinavir 56 herpes viruses 56 HMPV 56 elevated ALT 56 antiandrogen 56 Zolopa 56 ELISpot 56 rifabutin 56 HIV coinfection 56 cobiprostone 56 Twinrix 56 CTAP# Capsules 56 TTR gene 56 antibody titers 56 immunodeficiency disorders 56 prostate carcinoma 56 S. pneumoniae 56 vector adenovirus serotype 56 UPLYSO 56 rheumatoid arthritis osteoarthritis ankylosing 56 viral hemorrhagic fevers 56 T1DM 56 Human papillomaviruses 56 prognostic indicator 56 Vaccine Recombinant 56 esophageal gastric 56 Invasive pneumococcal disease 56 hMPV 56 Chronic pancreatitis 56 vaccine LAIV 56 pyrimethamine 56 untreated celiac disease 56 Neisseria meningitides 56 bladder carcinoma 56 cardioembolic stroke 56 gp# protein [002] 56 C. difficile toxins 56 oligodendrogliomas